In addition, it has been demonstrated that the copy number loss of CDKN2A could be an effective prognostic biomarker to independently predict poor survival in human papilloma virus (HPV)-negative HNSCC (40). Here, CDKN2A is linked to head and neck squamous cell carcinoma.